Treace Medical Concepts (TMCI) Payables (2020 - 2026)

Treace Medical Concepts' Payables history runs 7 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• Quarterly Payables rose 15.41% year-over-year to $15.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 15.41% YoY) and the FY2025 annual result came in at $8.5 million, down 19.49% from the prior year.
• Payables was $15.3 million for Q1 2026 at Treace Medical Concepts, up from $8.5 million in the prior quarter.
• Across five years, Payables topped out at $21.1 million in Q1 2024 and bottomed at $3.1 million in Q2 2022.
• A 5-year average of $11.8 million and a median of $10.5 million in 2024 frame the typical range for Payables.
• Annual changes were most pronounced in 2024 — Payables jumped 316.65% — and 2025, when it plunged 37.26%.
• Treace Medical Concepts' Payables stood at $8.7 million in 2022, then surged by 36.54% to $11.8 million in 2023, then declined by 11.09% to $10.5 million in 2024, then decreased by 19.49% to $8.5 million in 2025, then jumped by 80.77% to $15.3 million in 2026.
• Business Quant data shows TMCI's Payables at $15.3 million in Q1 2026, $8.5 million in Q4 2025, and $17.9 million in Q3 2025.